| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 10.236 | 35.624 | 44.209 | 15.916 |
| Total Income - EUR | - | - | - | - | - | - | 10.236 | 35.624 | 44.209 | 15.916 |
| Total Expenses - EUR | - | - | - | - | - | - | 346 | 1.295 | 7.013 | 10.291 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 9.890 | 34.329 | 37.196 | 5.625 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 9.589 | 33.286 | 36.776 | 5.219 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Meditidem S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 3.877 | 2.571 |
| Current Assets | - | - | - | - | - | - | 10.015 | 43.217 | 78.003 | 83.596 |
| Inventories | - | - | - | - | - | - | 12 | 12 | 12 | 11 |
| Receivables | - | - | - | - | - | - | 9.537 | 42.518 | 76.640 | 81.840 |
| Cash | - | - | - | - | - | - | 466 | 687 | 1.352 | 1.744 |
| Shareholders Funds | - | - | - | - | - | - | 9.629 | 42.945 | 79.590 | 84.364 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 462 | 272 | 2.290 | 1.802 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6290 - 6290" | |||||||||
| CAEN Financial Year |
6209
|
|||||||||
Comments - Meditidem S.r.l.